Evidence map›Paper›PMID 25950900›Full record

ReviewParasite (Paris, France)2015

Multilocus microsatellite typing of Leishmania and clinical applications: a review.

Srikanth Aluru, Mallorie Hide, Gregory Michel, Anne-Laure Bañuls, Pierre Marty, Christelle Pomares

Abstract readReview
In one paragraph

Review in Parasite (Paris, France), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Srikanth AluruAix-Marseille Université, Marseille, France - INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la Relation Hôte Pathogènes, 06204 Nice Cedex 3, France.
Mallorie HideUMR MIVEGEC IRD 224-CNRS 5290, Universités Montpellier 1 et 2, Montpellier, France.
Gregory MichelINSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la Relation Hôte Pathogènes, 06204 Nice Cedex 3, France - Université de Nice Sophia Antipolis, Faculté de Médecine, 06107 Nice Cedex 2, France.
Anne-Laure BañulsUMR MIVEGEC IRD 224-CNRS 5290, Universités Montpellier 1 et 2, Montpellier, France.
Pierre MartyINSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la Relation Hôte Pathogènes, 06204 Nice Cedex 3, France - Université de Nice Sophia Antipolis, Faculté de Médecine, 06107 Nice Cedex 2, France - Parasitologie-Mycologie, Centre Hospitalier Universitaire l'Archet, CS 23079, 06202 Nice Cedex 3, France.
Christelle PomaresINSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, C3M, Toxines Microbiennes dans la Relation Hôte Pathogènes, 06204 Nice Cedex 3, France - Université de Nice Sophia Antipolis, Faculté de Médecine, 06107 Nice Cedex 2, France - Parasitologie-Mycologie, Centre Hospitalier Universitaire l'Archet, CS 23079, 06202 Nice Cedex 3, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microsatellite markers have been used for Leishmania genetic studies worldwide, giving useful insight into leishmaniasis epidemiology. Understanding the geographic distribution, dynamics of Leishmania populations, and disease epidemiology improved markedly with this tool. In endemic foci, the origins of antimony-resistant strains and multidrug treatment failures were explored with multilocus microsatellite typing (MLMT). High genetic variability was detected but no association between parasite genotypes and drug resistance was established. An association between MLMT profiles and clinical disease manifestations was highlighted in only three studies and this data needs further confirmation. At the individual level, MLMT provided information on relapse and reinfection when multiple leishmaniasis episodes occurred. This information could improve knowledge of epidemiology and guide therapeutic choices for active chronic visceral leishmaniasis, the disease form in some HIV-positive patients.

Indexed as

Multilocus Sequence TypingAIDS-Related Opportunistic InfectionsAntiprotozoal AgentsDNA, ProtozoanDrug ResistanceEndemic DiseasesGenetic VariationHumansLeishmaniaMicrosatellite RepeatsPredictive Value of TestsRecurrenceAntiprotozoal AgentsDNA, Protozoan

Identifiers

PMID25950900
PMCPMC4423940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.